Dr. Suresh Rattan, Recognized Expert in Aging, Appointed to Senetek's Research Professorship at the University of Aarhus, Denmark
NAPA, Calif. and AARHUS, Denmark, Jan. 25 /PRNewswire-FirstCall/ -- Senetek PLC (Nasdaq: SNTKY - news), senetekplc.com, a biopharmaceutical company that develops products in two key markets, sexual dysfunction and skincare/dermatological, today announced that Suresh I.S. Rattan, Ph.D., D.Sc., an internationally recognized scientist in the field of Molecular Gerontology, has been chosen to head the Senetek Research Professorship at the Danish Centre for Molecular Gerontology, University of Aarhus.
The Senetek Research Professorship has been established to further the study and development of therapeutic compounds in the areas of anti-aging and skincare/dermatologicals. This comprehensive new research program, with a dedicated laboratory and staff, will operate under the direct supervision of Dr. Rattan.
Dr. Rattan has published more than 100 papers on various aspects of gerontology in scientific journals and is a recognized expert in developing the concept of hormesis, the effect of stress on health and the longevity of cells. He earned his Ph.D. from the Division of Genetics, National Institute for Medical Research, Mill Hill, London, UK, and has earned his D.Sc. from the University of Aarhus. Dr. Rattan's affiliations include:
-- Editor-in-Chief of the journal Biogerontology
-- Founding member, Australian Society of Cellular and Molecular
Gerontology
-- Special Advisor, American Society for Healthy Aging
-- Member, British Society for Research on Aging
-- Scientific Member, American Academy of Anti-Aging Medicine
-- Member, New York Academy of Sciences, USA
-- Member, International Association of Biomedical Gerontology, USA
-- Member, Danish Gerontological Society, Denmark
-- Fellow of the Royal Commonwealth Society, London
-- Editorial Board Member, Journal of Anti-Aging Medicine
Frank J. Massino, Senetek Chairman and CEO, said, ``We are most pleased to be working with a scientist as renowned as Dr. Rattan for furthering research in the areas of anti-aging and skincare/dermatologicals. Through this collaboration we look forward to accelerating the development of Zeatin and screening new compounds, as well as identifying new applications for Kinetin.''
The University of Aarhus (http://www.au.dk), established in 1928, consists of five faculties. It has a permanent scientific staff of 1,500 and a similar number of technical-administrative staff. The University's acclaimed programs serve an enrollment of more than 20,000 graduate and undergraduate students and approximately 700 Ph.D. candidates. In 1997, a member of the Aarhus University staff was awarded the Nobel Prize in Chemistry.
Senetek PLC, headquartered in Napa, California, is a science driven biopharmaceutical company engaged in the development of skincare/dermatological and sexual dysfunction products. Kinetin, the Company's patented anti-aging skincare technology, has been licensed to leading cosmetic and dermatological companies worldwide. Invicorp(TM) is Senetek's technology for the treatment of Erectile Dysfunction, a condition suffered by more than 100 million men worldwide. To learn more about Senetek, visit the Company's Web site at senetekplc.com .
Safe Harbor Statement:
This news release may contain statements that may be considered ``forward looking statements'' under the Federal securities laws, including statements concerning the revenue and licensing income we may receive in the future under licenses of our products, and the additional licensing agreements we may enter into during 2002. No forward-looking statement we make is a guarantee of future performance or events. Actual results or events may differ materially from those in the forward-looking statements as a result of various factors, including the risks and uncertainties described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2001 filed with the Securities and Exchange Commission.
SOURCE: Senetek PLC |
